Centroderm
Centroderm GmbH is a Wuppertal-based dermatology clinic and clinical trial site that provides clinical dermatology, laser treatments, and operative dermatology to patients, and serves pharmaceutical sponsors as a Phase 2 dermatology trial site.
- Company typePrivate
- Founded-
- HeadquartersWuppertal, Germany
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Centroderm does
Centroderm GmbH is a German private limited company headquartered in Wuppertal that operates a specialized dermatology clinic and clinical trial site. The firm offers clinical dermatology services to patients — including laser treatments and operative dermatology — under the leadership of founder and Chief Doctor Thomas Dirschka. In parallel, Centroderm has positioned itself as a contract clinical trial site for pharmaceutical and biotechnology sponsors developing dermatological therapeutics, providing patient enrollment, in-study clinical procedures, and regulatory-compliant data collection.
The company's core business activity is performing as a clinical research site. Its Wuppertal facility has completed the regulatory requirements and medical team training necessary to conduct Phase 2b dermatology studies, and was selected as the trial site for Vidac Pharma Holdings PLC's Phase 2b study of VDA-1102 topical ointment for highly proliferative Actinic Keratosis lesions. The core technology is specialized dermatology clinical research infrastructure: trained investigators, GCP-compliant processes, and patient access for skin-condition trials. There is no disclosed proprietary software, platform, or technology stack beyond standard clinical trial operations.
Centroderm's revenue model is professional services. Fees for clinical trial site operations are negotiated on a per-study basis with pharmaceutical sponsors, with pricing not publicly disclosed. The go-to-market motion is enterprise field sales — driven by industry reputation and regulatory credentials rather than broad marketing — targeting pharmaceutical and biotech companies as the primary customer segment. With 11-50 employees and a single site, Centroderm is a small specialist operator combining a patient-facing dermatology practice with a niche B2B contract research capability.
Centroderm firmographics
Firmographics- Name
- Centroderm
- Legal name
- Centroderm GmbH
- Website
- https://centroderm.de
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Centroderm GmbH is a Wuppertal-based dermatology clinic and clinical trial site that provides clinical dermatology, laser treatments, and operative dermatology to patients, and serves pharmaceutical sponsors as a Phase 2 dermatology trial site.
- Ownership category
- akta.pro rank
Centroderm industry classification
Industry- Product category
- Dermatology Services and Clinical Research
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Medical Laboratories (8071)
- akta.pro primary industry
- General & Medical Dermatology (HLAKACAA)
- akta.pro secondary industry
- Clinical Research & Trial Central Laboratories (HLAFAMAL)
Keywords
Where Centroderm is headquartered
LocationHeadquarters
- HQ city
- Wuppertal
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
Centroderm business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Clinical Trial Services: Centroderm GmbH provides clinical trial site services for pharmaceutical companies conducting dermatology research. Revenue is generated through conducting patient enrollment, clinical procedures, and data collection for Phase 2 clinical studies.
Go-to-market motion1 record
Centroderm product offering
Product offeringCore offering
Centroderm is a dermatology clinic and clinical trial site headquartered in Wuppertal, Germany. It delivers dermatology consultations and treatments, laser dermatology, and operative dermatology procedures to patients, and provides sponsor-facing clinical research services — including principal investigator oversight and patient recruitment — for dermatology drug development programs. The site has been selected to run contracted clinical studies such as the Vidac Pharma Phase 2b trial of VDA-1102 in actinic keratosis.
Differentiator
Problem solved
Functional benefit
Products and services
- Dermatology consultation and treatment Diagnostic and therapeutic dermatology services delivered to patients at Centroderm's clinic in Wuppertal, Germany, covering skin conditions and general dermatologic care.
- Laser dermatology treatments Laser-based dermatology procedures provided to patients at Centroderm's clinic for skin-related indications, delivered as part of the practice's treatment offerings.
- Operative dermatology Surgical dermatology procedures performed on patients at Centroderm's clinic as part of its on-site dermatology service offering.
- Clinical trial site services for dermatology studies Contracted clinical research services sold to pharmaceutical and biotech sponsors, including acting as an investigator site, principal investigator oversight, and patient recruitment for dermatology clinical trials.
Companies that use Centroderm
Customer profileNamed customers1 record
Segments1 record
Ideal customer profiles1 record
Centroderm technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Centroderm partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Vidac Pharma Holdings PLCcoreVidac Pharma Holdings PLC partnered with Centroderm GmbH to conduct a Phase 2b clinical study evaluating VDA-1102 for highly proliferative Actinic Keratosis lesions. Centroderm's facility in Wuppertal, Germany was selected following completion of regulatory requirements and training of the medical team. This partnership supports Vidac's clinical development planning and may inform the design of a potential Phase 3 registration study.
Scale indicators1 record
Recent moves3 records
Expansion highlights3 records
Centroderm competitors and assessment
Company assessmentDirect peers
- Dermatest: Dermatest is a German dermatological research institute that conducts clinical studies for cosmetics, pharmaceuticals, and medical devices on skin. It directly parallels Centroderm's dermatology clinical research activities in the German market.
- Bioskin: Bioskin is a dermatology-focused CRO offering Phase I-IV clinical trials and laboratory services for skin therapeutics, headquartered in Germany. It competes directly with Centroderm for dermatology clinical trial contracts from pharmaceutical sponsors.
- proDERM: proDERM is a Hamburg-based dermatology-focused contract research organization offering clinical trials and testing services for skin care products and pharmaceuticals. It is the most direct comparable to Centroderm as a Germany-based dermatology-specialized clinical trial site serving pharmaceutical sponsors.
Broad incumbents
- Parexel: Parexel is a major global CRO offering dermatology clinical development services across multiple geographies and phases. It represents the established, large-scale alternative for sponsors seeking dermatology trial execution.
- ICON plc: ICON is a global CRO with extensive dermatology and Phase 2/3 site operations worldwide. As a broad incumbent, it competes for dermatology sponsor work that Centroderm would otherwise target, particularly for multi-country studies.
- IQVIA: IQVIA is a global CRO with dermatology clinical trial capabilities and a broad site network. It represents the large, multi-geography incumbent alternative to specialty sites like Centroderm for sponsors running multi-site dermatology programs.
- Charles River Laboratories: Charles River provides clinical research services including dermatology trial support through its early-stage and site-services network. It is comparable as a broad life-sciences services incumbent serving pharmaceutical dermatology pipelines.
- SGS Health Sciences: SGS offers clinical research and bioanalytical laboratory services for pharmaceutical clients including dermatology studies. It is comparable as a broad life-sciences services provider capable of running dermatology clinical programs.
Emerging players
- Medicover: Medicover operates clinical research sites and healthcare facilities across Central and Eastern Europe, including dermatology offerings. It overlaps with Centroderm as a regionally-focused clinical trial operator, though at a larger multi-site scale.
Regional players
- Universitätsklinikum Dermatologie (University Hospital Dermatology Departments): German university hospital dermatology departments (e.g., Charité Berlin, Universitätsklinikum Würzburg) conduct Phase 2/3 dermatology trials as academic centers. They represent an alternative sponsor site option, competing with Centroderm on academic credibility and patient pool, though with different operating economics.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
Centroderm social profiles
Digital presenceCentroderm financial estimates
Financial estimateRevenue estimate
Valuation estimate
Centroderm leadership team
Management profileNumber of profiles
Profiles1 record
Centroderm funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Centroderm M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Centroderm
What does Centroderm do?
Centroderm is a dermatology clinic and clinical trial site headquartered in Wuppertal, Germany. It delivers dermatology consultations and treatments, laser dermatology, and operative dermatology procedures to patients, and provides sponsor-facing clinical research services — including principal investigator oversight and patient recruitment — for dermatology drug development programs. The site has been selected to run contracted clinical studies such as the Vidac Pharma Phase 2b trial of VDA-1102 in actinic keratosis.
Is Centroderm a public or private company?
Centroderm is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Centroderm founded?
Centroderm was founded in -1. It employs 11 to 50 people.
Where is Centroderm based?
Centroderm is headquartered in Wuppertal, Germany, in the Europe region.
How does Centroderm make money?
One revenue line is on record: clinical Trial Services.
Who are Centroderm's main competitors?
Direct peers on record are Dermatest, Bioskin and proDERM. Broad incumbents are Parexel, ICON plc, IQVIA, Charles River Laboratories and SGS Health Sciences. Medicover is listed as an emerging player. Universitätsklinikum Dermatologie (University Hospital Dermatology Departments) is listed as a regional player.
Does Centroderm have an API?
No public API is recorded for Centroderm.
What industry is Centroderm in?
Centroderm's product category is Dermatology Services and Clinical Research. Its primary akta.pro industry code is HLAKACAA, General & Medical Dermatology, with a secondary code of HLAFAMAL, Clinical Research & Trial Central Laboratories. Its NAICS code is 621511 and its SIC code is 8011.